APA (7th ed.) Citation

Jasmina, S., Ksenija, B., Milotka, F., Tatjana, C., Petar, S., Darko, N., . . . Željko, M. Real-life data on the efficacy and safety of ombitasvir/paritaprevir/ritonavir + dasabuvir +ribavirin in the patients with genotype 1 chronic hepatitis C virus infection in Serbia. Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade.

Chicago Style (17th ed.) Citation

Jasmina, Simonović-Babić, et al. Real-life Data on the Efficacy and Safety of Ombitasvir/paritaprevir/ritonavir + Dasabuvir +ribavirin in the Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Serbia. Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade.

MLA (9th ed.) Citation

Jasmina, Simonović-Babić, et al. Real-life Data on the Efficacy and Safety of Ombitasvir/paritaprevir/ritonavir + Dasabuvir +ribavirin in the Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Serbia. Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade.

Warning: These citations may not always be 100% accurate.